Nurse Anesthetist - CR in North Charleston, SC Accepting Medicare

4 Nurse Anesthetist - CR nurses found. Showing 1 - 4

Melanie Schmucker Ulm, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2690 Lake Park Dr, North Charleston, SC 29406 Phone: 843-572-1228    Fax: 843-576-6168

Deborah K Arnold, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2690 Lake Park Dr, North Charleston, SC 29406 Phone: 843-553-7070    Fax: 843-553-2223

Janet S Hall, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2690 Lake Park Dr, North Charleston, SC 29406 Phone: 843-553-7070    Fax: 843-553-2223

Bonita J Adamson, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2671 Elms Plantation Blvd, North Charleston, SC 29406 Phone: 843-797-6800

News Archive

Parent-only treatments for childhood obesity work effectively: Researchers

A study led by a researcher at the University of California, San Diego School of Medicine indicates that parent-only treatments for childhood obesity work equally as well as plans that include parents and child, while at the same time more cost effective and potentially easier for families. The results were published today in the advanced online edition of the journal Obesity.

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.

Leaders discuss best practices, challenges for detecting counterfeit medications

During the opening of the 10th annual meeting of the International Society of Pharmacovigilance (ISoP) in Accra, Ghana, the country's "Vice President John Dramani Mahama on Wednesday called on member countries of the society to institute effective measures that would help detect fake and counterfeit drugs," Ghana News Agency reports.

Genalyte completes $44 million in Series C Financing round

Genalyte, Inc. announced today it has completed a Series C Financing round of $44 million, led by Khosla Ventures. The company is redefining diagnostics with a testing platform and microchip technology that can be utilized in physician offices. With the application of a single drop of blood to a silicon microchip, Genalyte's Maverick Detection System can offer a complete panel of diagnostic test results in fifteen minutes.

Read more Medical News

› Verified 8 days ago